MSB 1.50% $1.18 mesoblast limited

Ann: Trading halt, page-154

  1. 1,609 Posts.
    lightbulb Created with Sketch. 1691
    I think it's most likely your #2, don't forget they have a licensee with skin in the game for this indication, and that licensee will have their own thoughts on whether to halt the trial or continue it, strategy on approaching FDA, etc. They would need time to discuss with Novartis.

    Better too, to halt immediately and stop any further deterioration in share price, which impacts the amount of equity Novartis gets for its $25 million.
    Last edited by dplane: 16/12/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.18
Change
0.018(1.50%)
Mkt cap ! $1.358B
Open High Low Value Volume
$1.15 $1.20 $1.15 $1.183M 1.011M

Buyers (Bids)

No. Vol. Price($)
17 64675 $1.18
 

Sellers (Offers)

Price($) Vol. No.
$1.19 37319 4
View Market Depth
Last trade - 10.55am 16/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.